David Steenblock, D.O., Uses EDTA Chelation for a Variety of Regenerative Medicine Therapies
Jun 01, 2017 11:22 am UTC| Business
SAN CLEMENTE, Calif., June 01, 2017 -- David Steenblock, an osteopathic physician based in San Clemente, CA, is uniquely qualified to address toxicity in the human body through his use of EDTA Chelation Therapy. Dr....
David Steenblock, D.O., Uses EDTA Chelation for a Variety of Regenerative Medicine Therapies
Jun 01, 2017 11:22 am UTC| Business
SAN CLEMENTE, Calif., June 01, 2017 -- David Steenblock, an osteopathic physician based in San Clemente, CA, is uniquely qualified to address toxicity in the human body through his use of EDTA Chelation Therapy. Dr....
David Steenblock, D.O., Uses EDTA Chelation for a Variety of Regenerative Medicine Therapies
Jun 01, 2017 11:22 am UTC| Business
SAN CLEMENTE, Calif., June 01, 2017 -- David Steenblock, an osteopathic physician based in San Clemente, CA, is uniquely qualified to address toxicity in the human body through his use of EDTA Chelation Therapy. Dr....
David Steenblock, D.O., Uses EDTA Chelation for a Variety of Regenerative Medicine Therapies
Jun 01, 2017 11:22 am UTC| Business
SAN CLEMENTE, Calif., June 01, 2017 -- David Steenblock, an osteopathic physician based in San Clemente, CA, is uniquely qualified to address toxicity in the human body through his use of EDTA Chelation Therapy. Dr....
Jun 01, 2017 11:21 am UTC| Business
SALT LAKE CITY, June 01, 2017 -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today that it will present three posters describing the reliability and effectiveness of its...
Mitek Announces Newest Release of its Patented Mobile Deposit® Solution
Jun 01, 2017 11:21 am UTC| Business
SAN DIEGO and LONDON, June 01, 2017 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader inmobile captureand identity verification software solutions, today announced the latest release of its market-leading...
Jun 01, 2017 11:21 am UTC| Business
SALT LAKE CITY, June 01, 2017 -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today that it will present three posters describing the reliability and effectiveness of its...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows